|
News for: |
|
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
FDA Approval Activities for this Drug…
Combivir (lamivudine/zidovudine) Tablets, 150mg and 300mg GlaxoSmithKline NDA 20-857/S-012 10/8/02 10/11/01 10/8/02 Combivir (lamivudine/zidovudine) Tablets, 150mg and 300mg GlaxoSmithKline NDA 20-857/S-009 & 20-857/S-010 Epivir (lamivudine), Tablets and solution, 150mg, GlaxoSmithKline NDA 20-564/S-016 & 20-596/S-017 3/1/02 3/5/02 Epivir (lamivudine), Tablets and solution, 150mg, GlaxoSmithKline NDA 20-564/S-015 & 20-596/S-016 6/24/02 7/2/02 6/25/02 Epivir (lamivudine), Tablets and solution, 150mg, GlaxoSmithKline NDA 20-564/S-014 & 20-596/S-015 10/8/02 10/11/01 10/8/02 Epivir (lamivudine), Tablets and solution, 150mg, GlaxoSmithKline NDA 20-564/S-012 & 20-596/S-013 3/6/01 4/26/01 Epivir-HBV (Lamivudine) Tablets & Solution, 100 mg & 5 mg/mL, GlaxoSmithKline NDA 21-003/S2 & 21-004/S2 Epivir (lamivudine), Tablets and solution, GlaxoSmithKline Epivir-HBV (Lamivudine) Tablets & Solution, GlaxoSmithKline Combivir (lamivudine/zidovudine) tablets, GlaxoSmithKline EPZICOM [abacavir sulfate (equivalent to 600 mg abacavir) and lamivudine (300 mg)] fixed dose combination Tablets, GlaxoSmithKline, Approval | EPIVIR- HBV (lamivudine) tablets, GlaxoSmithKline, Labeling Revision | EPIVIR- HBV (lamivudine) oral solution, GlaxoSmithKline, Labeling Revision | Combivir (lamivudine/zidovudine) tablets, GlaxoSmithKline, Labeling Revision | EPIVIR (lamivudine) oral solution, GlaxoSmithKline, Labeling Revision | EPIVIR (lamivudine) tablets, GlaxoSmithKline, Labeling Revision | EPIVIR (lamivudine) tablets, GlaxoSmithKline, Labeling Revision | EPIVIR (lamivudine) oral solution, GlaxoSmithKline, Labeling Revision | EPIVIR- HBV (lamivudine) tablets, GlaxoSmithKline, Labeling Revision | EPIVIR- HBV (lamivudine) oral solution, GlaxoSmithKline, Labeling Revision | Lamivudine/Zidovudine Tablets co-packaged w/Nevirapine Tablets, Pharmacare Limited, Tentative Approval | Lamivudine Tablets, Ranbaxy Labs, Tentative Approval | Lamivudine Tablets, Aurobindo Pharma, Tentative Approval | Lamivudine and Zidovudine Tablets, Aurobindo Pharma, Approval | Lamivudine Oral Solution, Aurobindo Pharma, Tentative Approval | Epivir (lamivudine) Tablets, GlaxoSmithKline, Labeling Revision | Epivir (lamivudine) Oral Solution, GlaxoSmithKline, Labeling Revision | Lamivudine Oral Solution, Cipla Ltd., Tentative Approval | Combivir (lamivudine/zidovudine) Tablets, GlaxoSmithKline, Labeling Revision | Lamivudine 150mg/Zidovudine 300mg Tablets Co-Packaged with Abacavir Sulfate 300mg Tablets, Aurobindo Pharma, Approval | Epzicom (abacavir sulfate/lamivudine) tablets, GlaxoSmithKline, Labeling Revision | Trizivir (abacavir sulfate/lamivudine/zidovudine) tablets, GlaxoSmithKline, Labeling Revision | Lamivudine and Zidovudine Tablets, Aurobindo Pharma, Tentative Approval | Lamivudine/Zidovudine Tablets, Cipla Ltd., Tentative Approval | COMBIVIR (lamivudine/ zidovudine) tablets, GlaxoSmithKline, Labeling Revision | EPIVIR (lamivudine) oral solution, GlaxoSmithKline, Labeling Revision | EPIVIR (lamivudine) tablets, GlaxoSmithKline, Labeling Revision | Lamivudine, Stavudine, Nevirapine Tablets, Cipla Ltd., Tentative Approval | Lamivudine/Zidovudine Tablets co-packaged w/Nevirapine Tablets, Pharmacare Ltd., Tentative Approval | Lamivudine Stavudine Tablets, Cipla Ltd., Tentative Approval | Lamivudine/Zidovudine/Nevirapine Tablets, Aurobindo Pharma, Approval | Lamivudine/Zidovudine/Nevirapine Tablets, Cipla Ltd., Tentative Approval | Stavudine/Lamivudine Tablets Co-packaged with Nevirapine Tablets, Strides Arcolab, Tentative Approval | Stavudine/Lamivudine Tablets, Strides Arcolab, Tentative Approval
|